PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

OBJECTIVE: To investigate the frequency of PD-1 and LAG-3-positive T cells in relapsed/refractory multiple myeloma (RRMM) patients and its clinical significance. METHODS: This prospective observational study enrolled a total of 71 RRMM patients, as well as 70 MM patients (non-refractory) and 70 heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming, Zhu, Jinlian, Yang, Xuedong, Yao, Jianxin, Liu, Yuqing, Liu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761990/
https://www.ncbi.nlm.nih.gov/pubmed/36529769
http://dx.doi.org/10.1186/s40001-022-00923-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761990/
https://www.ncbi.nlm.nih.gov/pubmed/36529769
http://dx.doi.org/10.1186/s40001-022-00923-5

Ejemplares similares